PAVmed Inc.
PAVM
$0.461
$0.04019.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -25.00% | -20.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.00% | -20.00% | |||
| Cost of Revenue | 13.89% | -25.00% | |||
| Gross Profit | -25.00% | 26.32% | |||
| SG&A Expenses | -16.00% | 6.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.44% | 4.95% | |||
| Operating Income | 13.42% | -4.99% | |||
| Income Before Tax | -166.18% | 1,530.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -166.18% | 1,530.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 16.81% | 19.38% | |||
| Net Income | -162.85% | 1,225.51% | |||
| EBIT | 13.42% | -4.99% | |||
| EBITDA | 13.14% | -5.57% | |||
| EPS Basic | -157.71% | 925.91% | |||
| Normalized Basic EPS | 62.76% | -33.33% | |||
| EPS Diluted | -317.65% | 2,886.89% | |||
| Normalized Diluted EPS | -40.98% | -327.08% | |||
| Average Basic Shares Outstanding | 30.33% | 28.15% | |||
| Average Diluted Shares Outstanding | -65.55% | -60.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||